Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease

Successful treatment of chronic graft-versus-host disease (GvHD) often requires long-term systemic therapy (ST). Durable discontinuation of ST reflects the resolution of active chronic GvHD. We evaluated the factors associated with durable ST discontinuation, defined as cessation of all ST for ≥12 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, George L., Onstad, Lynn, Martin, Paul J., Carpenter, Paul, Pidala, Joseph, Arai, Sally, Cutler, Corey, Hamilton, Betty K., Lee, Stephanie J., Arora, Mukta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Complications in Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890023/
https://www.ncbi.nlm.nih.gov/pubmed/35615925
http://dx.doi.org/10.3324/haematol.2021.279814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890023/
https://www.ncbi.nlm.nih.gov/pubmed/35615925
http://dx.doi.org/10.3324/haematol.2021.279814

Ejemplares similares